TP53 alterations in relapsed childhood acute lymphoblastic leukemia

Chih-Hsiang Yu1, Wan-Ting Chang2, Shiann-Tarng Jou3

  • 1Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Cancer Science
|November 16, 2019
PubMed
Summary

TP53 gene alterations frequently emerge during relapse in childhood acute lymphoblastic leukemia (ALL). These TP53 alterations significantly worsen survival outcomes and are valuable prognostic markers in relapsed pediatric ALL patients.